R. Garg, Mona Piplani, Yogendra Pratap Singh, Pankaj Bhateja, R. Rana
{"title":"An Overview of Integrated Risk Factors with Prevention and Prevalence of Asthma at the Global Level","authors":"R. Garg, Mona Piplani, Yogendra Pratap Singh, Pankaj Bhateja, R. Rana","doi":"10.2174/2215083810666230525153908","DOIUrl":null,"url":null,"abstract":"\n\nBronchial asthma is one of the most common chronic illnesses in childhood, adulthood and pregnancy with a current occurrence of 6-9 percent, but at an alarming rate of increase. Asthma is a complex genetic disorder that is heavily affected by the environment. In association with significant morbidity, quality of life, and healthcare costs, it is putting an increasing strain on our society. Some factors related to pregnancy, i.e., diet-related, antibiotic uses, and stress; childhood risk factors, i.e., lung function, exposure to smoking, animal etc. and adulthood risk factor, i.e., pollution-related etc., are responsible for trends in incidence and mortality due to asthma at a Global level and Indian population. Data were collected from PubMed, Web of Sciences, CINHAL, WHO Clinical trial register, Google Scholar, and official websites of various asthma societies and statistically analyzed using ANOVA tests. Data were analyzed for India and the specific population of the northern region of India during the last five years. Risk factors related to asthma at different stages, i.e., genetic, pregnancy, childhood, and adulthood, were reviewed, and the prevalence of asthma at the Global level, India and northern India, was analyzed and compared. The mean Global prevalence of asthma was found to be 281.3±14.7 (SD), whereas, for India, it was 22.78±8.605. After applying One Way ANOVA, a significant difference (t=48.44, df=4) was found between the Global and Indian prevalence of asthma, i.e., the mean difference of 259.7±11.99. The mean value was found highest in Delhi and Rajasthan, having values of 19.74±11.79 and 13.58±9.47, whereas Chandigarh and Uttar Pradesh recorded asthma’s prevalence as 11.87±7.83 and 4.32±2.32 respectively. Himachal and Haryana acquired almost equal values of asthma at 1.67±0.13 and 1.23±0.33.\n","PeriodicalId":11026,"journal":{"name":"Current Traditional Medicine","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Traditional Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2215083810666230525153908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Bronchial asthma is one of the most common chronic illnesses in childhood, adulthood and pregnancy with a current occurrence of 6-9 percent, but at an alarming rate of increase. Asthma is a complex genetic disorder that is heavily affected by the environment. In association with significant morbidity, quality of life, and healthcare costs, it is putting an increasing strain on our society. Some factors related to pregnancy, i.e., diet-related, antibiotic uses, and stress; childhood risk factors, i.e., lung function, exposure to smoking, animal etc. and adulthood risk factor, i.e., pollution-related etc., are responsible for trends in incidence and mortality due to asthma at a Global level and Indian population. Data were collected from PubMed, Web of Sciences, CINHAL, WHO Clinical trial register, Google Scholar, and official websites of various asthma societies and statistically analyzed using ANOVA tests. Data were analyzed for India and the specific population of the northern region of India during the last five years. Risk factors related to asthma at different stages, i.e., genetic, pregnancy, childhood, and adulthood, were reviewed, and the prevalence of asthma at the Global level, India and northern India, was analyzed and compared. The mean Global prevalence of asthma was found to be 281.3±14.7 (SD), whereas, for India, it was 22.78±8.605. After applying One Way ANOVA, a significant difference (t=48.44, df=4) was found between the Global and Indian prevalence of asthma, i.e., the mean difference of 259.7±11.99. The mean value was found highest in Delhi and Rajasthan, having values of 19.74±11.79 and 13.58±9.47, whereas Chandigarh and Uttar Pradesh recorded asthma’s prevalence as 11.87±7.83 and 4.32±2.32 respectively. Himachal and Haryana acquired almost equal values of asthma at 1.67±0.13 and 1.23±0.33.
支气管哮喘是儿童、成年和妊娠期最常见的慢性疾病之一,目前发病率为6- 9%,但正以惊人的速度增长。哮喘是一种复杂的遗传疾病,受环境影响很大。它与显著的发病率、生活质量和医疗费用有关,正给我们的社会带来越来越大的压力。与怀孕有关的一些因素,即饮食相关、抗生素使用和压力;儿童期风险因素,即肺功能、接触吸烟、接触动物等,以及成年期风险因素,即与污染有关等,是全球和印度人口哮喘发病率和死亡率趋势的原因。数据收集自PubMed、Web of Sciences、CINHAL、WHO临床试验注册、谷歌Scholar和各哮喘学会官方网站,并采用方差分析(ANOVA)进行统计分析。数据分析了印度和印度北部地区的特定人口在过去五年中。回顾了不同阶段哮喘的相关危险因素,即遗传、妊娠、儿童期和成年期,并分析和比较了全球、印度和印度北部哮喘的患病率。全球平均哮喘患病率为281.3±14.7 (SD),而印度为22.78±8.605。采用单因素方差分析(One Way ANOVA),发现全球哮喘患病率与印度哮喘患病率之间存在显著差异(t=48.44, df=4),即平均差异为259.7±11.99。德里和拉贾斯坦邦的平均值最高,分别为19.74±11.79和13.58±9.47,昌迪加尔和北方邦的平均值分别为11.87±7.83和4.32±2.32。喜马偕尔邦和哈里亚纳邦的哮喘指数几乎相等,分别为1.67±0.13和1.23±0.33。
期刊介绍:
Current Traditional Medicine covers all the aspects of the modernization and standardization research on traditional medicine of the world, e.g. chemistry, pharmacology, molecular mechanism, systems biology, proteomics, genomics, metabolomics, safety, quality control, clinical studies of traditional Chinese, Ayurvedic, Unani, Arabic and other ethnomedicine. Each issue contains updated comprehensive in-depth/mini reviews along with high quality original experimental research articles. Current Traditional Medicine is a leading and important international peer-reviewed journal reflecting the current outstanding scientific research progresses of the global traditional, indigenous, folk and ethnologic medicine. It provides a bridge connected the tradition medicine system to the modern life science with the efforts of top scientists, as well as a resource to pursuit the solutions for the existing common issues in the traditional medicine.